Table 1.

Clinical characteristics of patients switched to aflibercept from ranibizumab

Average number of intraocular injections before	11.75±5.73 (6-25).
Aflibercept injection (average-interval)	3.44±0.73 (3-5)
BCVA values (average /logMAR-ETDRS letters)
Before aflibercept injection	1.08 (47.4 letters)
After aflibercept injection	0.80 (50 letters)
Central macular thickness (average-interval)
Before aflibercept injection	471.3 (97-1365)
After aflibercept injection	345.1 (97-585)
The mean height of PED
Before aflibercept injection	350.4 ± 151.7 (129-793)
After aflibercept injection	255.52 ± 156.8 (0-528)

BCVA: Best corrected visual acuity.

PED: Pigment epithelial detachment.